Oxford Pharmascience Group PLC (LSE:OXP) - Overview

Stock Report

Oxford Pharmascience Group PLC OXP

Last Price
£-

Day Change
-|-%

As of -
- | GBP
Minimum 15 Minutes Delay.

Last Close-
Day Range-
Mkt Cap19.89Mil
52-Wk Range-
Yield %-
ISINGB00B3LXPB43
Volume-
P/E-
P/S-
P/CF-

Share Price

Total Returns 06/12/2016

 Chg (%)  
More ...
Oxford Pharmascience Group PLC-22.35 
FTSE 100 TR GBP1.72
 
Financials
201320142015
More ...
Income Statement
Turnover1.030.710.75
Operating Profit-1.56-3.50-3.97
Net Profit-1.49-2.86-3.11
Reported EPS-0.17-0.29-0.28
Balance Sheet
Current Assets10.217.5624.05
Non Current Assets0.060.050.04
Total Assets10.277.6124.09
Current Liabilities0.370.290.31
Total Liabilities0.370.290.31
Total Equity9.907.3223.79
Cash Flow
Operating Cash Flow-1.26-3.63-3.72
Net Change in Cash7.72-3.246.35
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2016-2.78-0.17--9.59---
2017-3.81-0.25--6.52---

Company Profile

Oxford Pharmascience Group PLC is a specialty pharmaceutical company. It is engaged in the R&D and commercialization of drug products from proprietary technology platforms. It re-develops approved drugs to make them safer and easier to take.
 

Sector

Biotechnology

Market Position

1339 of 1865 Companies

Index

FTSE AIM All Share

Outlook

(07/09/2016) no outlook statement

Next Event 31/12/2016

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)-6.6713.2615.65
Div Yld (E)0.004.224.33
PEG (E)0.000.160.15
ROCE-16.32211.13-30.38
Op Mrgn-530.44-15.97-33.60
EPS Grwth0.0010.3023.33
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanRobert Norwood
Chief Executive OfficerMarcelo Bravo
Finance Director & Company SecretaryMr. Chris Hill
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.